2.62
Schlusskurs vom Vortag:
$2.64
Offen:
$2.6
24-Stunden-Volumen:
33,956
Relative Volume:
0.01
Marktkapitalisierung:
$45.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-4.73%
1M Leistung:
+0.00%
6M Leistung:
-34.34%
1J Leistung:
-21.79%
Mural Oncology Plc Stock (MURA) Company Profile
Firmenname
Mural Oncology Plc
Sektor
Branche
Telefon
353 1 905 8020
Adresse
10 EARLSFORT TERRACE, DUBLIN 2
Vergleichen Sie MURA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
MURA
Mural Oncology Plc
|
2.62 | 47.49M | 0 | 0 | 0 | 0.00 |
![]()
ONC
Beone Medicines Ltd Adr
|
245.58 | 26.10B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
442.05 | 111.96B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 42.96M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
81.20 | 6.39B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
490.28 | 63.52B | 14.09B | 4.50B | 2.96B | 39.28 |
Mural Oncology Plc Stock (MURA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-25 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2025-03-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
2024-06-28 | Eingeleitet | Rodman & Renshaw | Buy |
2024-04-04 | Eingeleitet | Morgan Stanley | Overweight |
Mural Oncology Plc Aktie (MURA) Neueste Nachrichten
Form 8.3Mural Oncology plc - Business Wire
BlackRock discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology - Investing.com Australia
Goldman Sachs adjusts positions in Mural Oncology By Investing.com - Investing.com South Africa
Goldman Sachs adjusts positions in Mural Oncology - Investing.com Australia
Goldman Sachs reports trading in Mural Oncology shares By Investing.com - Investing.com South Africa
Mural Oncology Announces Number of Relevant Securities in Issue - The Manila Times
Mural Oncology Discloses Share Count Under Irish Takeover Rules: What's Behind This Move? - Stock Titan
Goldman Sachs reports trading in Mural Oncology shares - Investing.com Australia
Mural Oncology plc (NASDAQ:MURA) Shares Sold by Price T Rowe Associates Inc. MD - Defense World
Goldman Sachs reveals stake in biopharmaceutical firm Mural Oncology - Dimsum Daily
Goldman Sachs discloses stake in Mural Oncology By Investing.com - Investing.com South Africa
Goldman Sachs discloses stake in biopharmaceutical firm Mural Oncology - Dimsum Daily
Goldman Sachs discloses stake in Mural Oncology - Investing.com
Goldman Sachs reports dealings in Mural Oncology shares By Investing.com - Investing.com Nigeria
Goldman Sachs reports dealings in Mural Oncology shares - Investing.com
BlackRock discloses stake in Mural Oncology plc By Investing.com - Investing.com South Africa
BlackRock discloses stake in Mural Oncology plc - Investing.com
BlackRock reports stake in Mural Oncology By Investing.com - Investing.com Canada
BlackRock reports stake in Mural Oncology - Investing.com
56,176 Shares in Mural Oncology plc (NASDAQ:MURA) Purchased by Raymond James Financial Inc. - Defense World
Layoff Tracker: IGM Axes 80% of Workforce - BioSpace
Finanzdaten der Mural Oncology Plc-Aktie (MURA)
Es liegen keine Finanzdaten für Mural Oncology Plc (MURA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):